Peptide Depots

Peptide Depots is a type of injectable depot formulation that specifically encapsulates or entraps peptide therapeutics within a biodegradable matrix or carrier system to enable sustained in vivo release over an extended period, distinguishing it from other depot systems by its tailored design for the controlled delivery of peptide molecules susceptible to rapid degradation and clearance.

8

Publications

532

Citations

48

Authors

13

Institutions

Publications per year

2017–2026

3

Authors

48

  1. XL
    Xinghai Li

    Duke University, United States

    2 publications · 119 citations

    2

    h-index

  2. SG
    Sylvestre Grizot

    Centre National de la Recherche Scientifique, France

    1 publications · 69 citations

    2

    h-index

  3. JR
    J. Richard

    Inserm, France

    1 publications · 69 citations

    2

    h-index

  4. AC
    Ashutosh Chilkoti

    Duke University, United States

    2 publications · 119 citations

    2

    h-index

  5. AS
    Albert Selva-O’Callaghan

    Universitat Autònoma de Barcelona, Spain

    1 publications · 18 citations

    1

    h-index

1–5 of 48

Venues

  1. Journal of Controlled Release

    2 publications · 294 citations

    3

    h-index

  2. Proceedings of the National Academy of Sciences

    PNAS · 1 publications · 94 citations

    1

    h-index

  3. Expert Opinion on Drug Delivery

    1 publications · 69 citations

    1

    h-index

  4. Biomaterials

    1 publications · 25 citations

    1

    h-index

  5. Journal of Pharmaceutical Sciences

    1 publications · 21 citations

    1

    h-index

1–5